Chugai Pharmaceutical Co Ltd ADR (CHGCY)

14.19
+0.27(+1.94%)
After Hours
14.18
-0.01(-0.07%)
- Delayed Data
  • Volume:
    170,924
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    13.63 - 14.19
High dividend Yield

Dividend yield shows how much a company pays its shareholders in dividends annually per dollar invested. It reflects how much an investor will earn aside from any capital gains in the stock.

CHGCY Overview

Prev. Close
13.92
Day's Range
13.63-14.19
Revenue
1.21T
Open
13.63
52 wk Range
10.99-15.41
EPS
192.19
Volume
170,924
Market Cap
46.59B
Dividend (Yield)
2.62
(11.52%)
Average Vol. (3m)
101,890
P/E Ratio
20.55
Beta
-
1-Year Change
5.11%
Shares Outstanding
1,645,132,319
Next Earnings Date
-
What is your sentiment on Chugai Pharma ADR?
or
Market is currently closed. Voting is open during market hours.

Chugai Pharmaceutical Co Ltd ADR Company Profile

Chugai Pharmaceutical Co Ltd ADR Company Profile

Employees
7771

Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, FoundationOne, Polivy, Rozlytrek, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, and Gazyva; Edirol, an Osteoporosis agent; Mircera, an erythropoiesis agent; Oxarol, an agent for secondary hyperparathyroidism; and other diseases comprise Hemlibra, CellCept, Bonviva, Tamiflu, Evrysdi, Ronapreve, Vabysmo, and Enspryng. It has various development product candidates in the areas of oncology, immunology, neuroscience, hematology, ophthalmology, and other diseases. Chugai Pharmaceutical Co., Ltd. has strategic alliances and collaboration with Roche Group. The company was founded in 1925 and is headquartered in Chuo, Japan. Chugai Pharmaceutical Co., Ltd. operates as a subsidiary of Roche Holding Ltd.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyBuy
Technical IndicatorsStrong BuyStrong BuyStrong BuyNeutralBuy
SummaryStrong BuyStrong BuyStrong BuyBuyBuy